生长抑素诱导的胰高血糖素抑制改善人胰岛素缺乏时葡萄糖耐量的可能机制。 - Suppr

Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.

作者信息

Liljenquist J E, Bloomgarden Z T, Cherrington A D, Perry J M, Rabin D

出版信息

Diabetologia. 1979 Sep;17(3):139-43. doi: 10.1007/BF01219739.

DOI:10.1007/BF01219739

PMID:510828

Abstract

摘要

相似文献

Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.

Diabetologia. 1979 Sep;17(3):139-43. doi: 10.1007/BF01219739.

Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.

Metabolism. 1978 Jul;27(7):849-53. doi: 10.1016/0026-0495(78)90219-6.

Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man.

Diabetes. 1983 Oct;32(10):943-7. doi: 10.2337/diab.32.10.943.

Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men.

Horm Res. 1998;49(5):221-5. doi: 10.1159/000023175.

Somatostatin and diabetes mellitus: the role of glucagon in diabetic hyperglycemia and glucose intolerance.

Scand J Clin Lab Invest. 1976 Oct;36(6):497-503. doi: 10.1080/00365517609054470.

Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.

Lancet. 1976 Dec 4;2(7997):1213-6. doi: 10.1016/s0140-6736(76)91142-9.

Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.

Diabetes. 1976 Dec;25(12):1091-9. doi: 10.2337/diab.25.12.1091.

Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.

J Clin Endocrinol Metab. 1979 Jan;48(1):171-5. doi: 10.1210/jcem-48-1-171.

The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.

Diabetes. 1996 May;45(5):552-6. doi: 10.2337/diab.45.5.552.

Hyperglycemia and glucagon suppression: possible importance of the vagus and enteric humoral factors.

J Clin Endocrinol Metab. 1979 Jan;48(1):13-6. doi: 10.1210/jcem-48-1-13.

引用本文的文献

Metabolic effects of glucagon in humans.

J Clin Transl Endocrinol. 2018 Dec 20;15:45-53. doi: 10.1016/j.jcte.2018.12.005. eCollection 2019 Mar.

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

J Clin Invest. 2012 Jan;122(1):4-12. doi: 10.1172/JCI60016. Epub 2012 Jan 3.

Islet-1 regulates Arx transcription during pancreatic islet alpha-cell development.

J Biol Chem. 2011 Apr 29;286(17):15352-60. doi: 10.1074/jbc.M111.231670. Epub 2011 Mar 9.

Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice.

Mol Endocrinol. 2010 Aug;24(8):1605-14. doi: 10.1210/me.2010-0120. Epub 2010 Jun 30.

The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.

J Clin Invest. 1996 Feb 1;97(3):642-8. doi: 10.1172/JCI118460.

本文引用的文献

Estimation of hepatic blood flow with indocyanine green.

J Clin Invest. 1962 May;41(5):1169-79. doi: 10.1172/JCI104570.

Importance of the hematocrit in interpretation of blood sugar.

Diabetes. 1965 Oct;14(10):672-4. doi: 10.2337/diab.14.10.672.

Hepatic vascular bed.

Physiol Rev. 1971 Jan;51(1):23-65. doi: 10.1152/physrev.1971.51.1.23.

Pancreatic glucagon secretion in normal and diabetic subjects.

Am J Med Sci. 1969 Jun;257(6):415-9. doi: 10.1097/00000441-196906000-00008.

Serum insulin levels following administration of exogenous insulin.

J Clin Endocrinol Metab. 1973 Jun;36(6):1175-9. doi: 10.1210/jcem-36-6-1175.

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

N Engl J Med. 1974 Sep 12;291(11):544-7. doi: 10.1056/NEJM197409122911102.

Metabolism of forearm tissues in man. Studies with glucagon.

Diabetes. 1976 Feb;25(2):128-35. doi: 10.2337/diab.25.2.128.

Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

N Engl J Med. 1976 Feb 26;294(9):455-61. doi: 10.1056/NEJM197602262940901.

Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon.

Diabetes. 1975 Jun;24(6):574-84. doi: 10.2337/diab.24.6.574.

Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus.

Diabetologia. 1977 Sep;13(5):537-44. doi: 10.1007/BF01234510.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献